A detailed history of Capstone Wealth Management Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capstone Wealth Management Group, LLC holds 3,516 shares of ABBV stock, worth $598,950. This represents 0.41% of its overall portfolio holdings.

Number of Shares
3,516
Previous 3,490 0.74%
Holding current value
$598,950
Previous $598,000 16.05%
% of portfolio
0.41%
Previous 0.39%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $4,259 - $5,182
26 Added 0.74%
3,516 $694,000
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $1,547 - $1,807
10 Added 0.29%
3,490 $598,000
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $6,232 - $7,101
39 Added 1.13%
3,480 $633,000
Q4 2023

Jan 11, 2024

BUY
$137.6 - $154.97 $29,859 - $33,628
217 Added 6.73%
3,441 $533,000
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $62,920 - $72,840
471 Added 17.11%
3,224 $480,000
Q2 2023

Jul 27, 2023

BUY
$132.51 - $164.9 $3,445 - $4,287
26 Added 0.95%
2,753 $370,000
Q1 2023

Apr 13, 2023

BUY
$144.61 - $166.54 $7,808 - $8,993
54 Added 2.02%
2,727 $434,000
Q4 2022

Jan 25, 2023

BUY
$138.31 - $165.87 $3,319 - $3,980
24 Added 0.91%
2,673 $0
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $46,570 - $53,413
347 Added 15.07%
2,649 $356,000
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $9,495 - $12,072
69 Added 3.09%
2,302 $353,000
Q1 2022

Apr 12, 2022

BUY
$131.98 - $163.75 $2,771 - $3,438
21 Added 0.95%
2,233 $362,000
Q4 2021

Apr 12, 2022

BUY
$107.43 - $135.93 $237,635 - $300,677
2,212 New
2,212 $299,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capstone Wealth Management Group, LLC Portfolio

Follow Capstone Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Wealth Management Group, LLC with notifications on news.